Literature DB >> 10405714

Tissue characterization in the female pelvis by means of MR imaging.

E S Siegelman1, E K Outwater.   

Abstract

Pelvic imaging techniques such as computed tomography and ultrasonography provide a limited capability for tissue characterization. Fat, fluid, and calcification, for example, can be identified on the basis of parameters such as x-ray attenuation, echogenicity, and sound attenuation. Because of the many tissue parameters, such as T1, T2, magnetic susceptibility, and chemical shift, that contribute to signal intensity, magnetic resonance (MR) imaging may afford an ability to identify a wider array of specific tissues. The purpose of this article is to review the ability of MR imaging to help identify various types of soft tissue and to provide an approach to interpretation of MR images of the female pelvis through tissue characterization. Lipid, fluid, hemorrhage, smooth muscle, fibrosis, solid malignant tissue, and hydrated soft tissue (including edema, mucin, and myxomatous tissue) have typical MR imaging properties, and their presence in a mass can often be established on MR images. Consideration of the tissue composition of various pathologic processes in the pelvis can result in more systematic approaches to image interpretation and thus narrow the differential diagnosis.

Entities:  

Mesh:

Year:  1999        PMID: 10405714     DOI: 10.1148/radiology.212.1.r99jl455

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  21 in total

1.  Nongynecological endometriosis presenting as an acute abdomen.

Authors:  Becky J Hwang; Nasima Jafferjee; Alberto Paniz-Mondolfi; Jeanne Baer; Kenneth Cooke; David Frager
Journal:  Emerg Radiol       Date:  2012-04-27

2.  Comparative evaluation of multidetector CT and MR imaging in the differentiation of adnexal masses.

Authors:  A C Tsili; C Tsampoulas; M Argyropoulou; I Navrozoglou; Y Alamanos; E Paraskevaidis; S C Efremidis
Journal:  Eur Radiol       Date:  2008-01-10       Impact factor: 5.315

Review 3.  Magnetic resonance imaging of vaginal and vulval pathology.

Authors:  N Griffin; L A Grant; E Sala
Journal:  Eur Radiol       Date:  2008-02-01       Impact factor: 5.315

4.  Contribution of diffusion-weighted MR imaging for predicting benignity of complex adnexal masses.

Authors:  Isabelle Thomassin-Naggara; Emile Daraï; Charles A Cuenod; Laure Fournier; Irwin Toussaint; Claude Marsault; Marc Bazot
Journal:  Eur Radiol       Date:  2009-02-13       Impact factor: 5.315

5.  Dynamic contrast-enhanced MR imaging to assess physiologic variations of myometrial perfusion.

Authors:  Isabelle Thomassin-Naggara; Daniel Balvay; Charles A Cuenod; Emile Daraï; Claude Marsault; Marc Bazot
Journal:  Eur Radiol       Date:  2009-10-10       Impact factor: 5.315

Review 6.  Systematic radiological approach to utero-ovarian pathologies.

Authors:  Olivera Nikolic; Marijana Basta Nikolic; Aleksandar Spasic; Mila Milagros Otero-Garcia; Sanja Stojanovic
Journal:  Br J Radiol       Date:  2019-06-06       Impact factor: 3.039

7.  Imaging Diagnosis of Urethral Leiomyoma, usual Tumour at an Unusual Location.

Authors:  Ritu Verma; Shibani Mehra; U C Garga; Nishchint Jain; Krishna Bhardwaj
Journal:  J Clin Diagn Res       Date:  2014-11-20

8.  Magnetic resonance imaging of painful total hip replacement: detection and characterisation of periprosthetic fluid collection and interobserver reproducibility.

Authors:  A Aliprandi; L M Sconfienza; F Randelli; M Bandirali; G Di Leo; F Sardanelli
Journal:  Radiol Med       Date:  2011-07-09       Impact factor: 3.469

9.  Parenchymal signal intensity in 3-T body MRI of dogs with hematopoietic neoplasia.

Authors:  Daniel A Feeney; Leslie C Sharkey; Susan M Steward; Katherine L Bahr; Michael S Henson; Daisuke Ito; Timothy D O'Brien; Carl R Jessen; Brian D Husbands; Antonella Borgatti; Jaime F Modiano
Journal:  Comp Med       Date:  2013-04       Impact factor: 0.982

Review 10.  PET/CT and cross sectional imaging of gynecologic malignancy.

Authors:  Revathy B Iyer; Aparna Balachandran; Catherine E Devine
Journal:  Cancer Imaging       Date:  2007-10-01       Impact factor: 3.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.